Walker 256 tumor MHC class I expression during the shift from A variant to the immunogenic AR variant.

doi:10.1016/j.canlet.2004.01.023

Article

Walker 256 tumor MHC class I expression during the shift from A variant to the immunogenic AR variant.

Cancer letters - 28 Jul 2004

Schanoski Alessandra Soares, Cavalcanti Tereza Cristina, Campos Cláudia Barbosa Ladeira, Viera-Matos Ana Neuza, Rettori Ovídio, Guimarães Fernando

Abstract excerpt

Novel tumor cell variants can be obtained by serially passaging tumor cells in different media and/or environments. Serial intraperitoneal (ip) passages of the Walker 256 tumor A variant was followed for studying the generation of its regressive AR variant. MHC class I molecule expression was assessed since variations in this molecule would explain changes in tumor cell immunogenicity and therefore, the shift...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Walker 256 tumor MHC class I expression during the shift from A variant to the immunogenic AR variant.

Abstract excerpt

Topics

Related research